Get the app Watchlists Portfolios Alerts Sign in Get started

Menu

Market-Moving News for January 7th

Benzinga Newsdesk Jan 7, 2026 9 months ago

MoversTrading Ideas

GLUE: 42% | Monte Rosa Therapeutics shares are trading higher after the company announced it will present interim clinical results from the ongoing Phase 1 study of NEK7-directed MGD MRT-8102. VTYX: 74% |

GLUE: 42% | Monte Rosa Therapeutics shares are trading higher after the company announced it will present interim clinical results from the ongoing Phase 1 study of NEK7-directed MGD MRT-8102.

VTYX: 74% | Ventyx Biosciences shares are trading higher after a WSJ report indicating Eli Lilly is nearing a deal to acquire the company.

CDIO: 45% | Cardio Diagnostics, Aimil And Dr. Lal PathLabs Collaborate To Bring PrecisionCHD Coronary Heart Disease Test To Indian Market

Read the original